A petition is being circulated to urge the FDA to reconsider its stance on peptides, as concerns grow about their potential ban. The risk of sourcing peptides from unreliable sources is highlighted, emphasizing the importance of safety and informed decisions. Additionally, there's a call for tech-savvy individuals to help establish a patient registry for those using peptides.
